Astrana Health, Inc.
Astrana Health, Inc.
ALHAMBRA, CA
Loading...
Price History
Market Data
| Market Cap | 1.95B |
| P/E Ratio | - |
| P/B Ratio | 2.51 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 2.13 |
| Current Ratio | 1.40 |
| Currency | USD |
Key Financial Metrics
3.18B
Revenue
22.49M
Net Income
-
EPS (Diluted)
221.09M
Free Cash Flow
Profitability
Gross Margin
10.7%
Operating Margin
2.5%
Net Profit Margin
0.7%
EBITDA
144.88M
Returns & Efficiency
Return on Assets (ROA)
1.0%
Return on Equity (ROE)
2.9%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
2.22B
Total Debt
990.90M
Debt to Equity
2.13x
Current Ratio
1.40
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Engineering, Accounting & Management Services |
| HQ | ALHAMBRA, CA |
| Fiscal Year | 2025 |
Peers
9.17B
P/E: --
5.78B
P/E: --
5.05B
P/E: 23.4
5.05B
P/E: 23.4
EXPONENT INC
EXPO
3.21B
P/E: 31.1
2.20B
P/E: 28.7
1.41B
P/E: --
NUKKLEUS INC.
NUKKW
1.41B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$1.95B
P/E Ratio (TTM)-
Price to Book2.51
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin10.7%
Operating Margin2.5%
Net Margin0.7%
ROE2.9%
ROA1.0%
Leverage & Liquidity
Debt to Equity2.13
Current Ratio1.40
Total Debt$990.90M
Total Assets$2.22B
Stockholders' Equity$779.29M
Income Statement (FY 2025)
Revenue$3.18B
Gross Profit$341.53M
Operating Income$78.53M
Net Income$22.49M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$221.09M
Cash & Equivalents$429.47M
Revenue Growth0.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA, CA 91801 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 870042699 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 55.60M |
| Stockholders' Equity | $779.29M |
| Cash & Equivalents | $429.47M |
Recent Filings
View All
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-17
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-17
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-15
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-08
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-08
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-08
Local
S-3ASR
Automatic Shelf Registration
Automatic shelf registration for well-known issuers
Filed: 2026-03-31
Local
S-3ASR
Automatic Shelf Registration
Automatic shelf registration for well-known issuers
Filed: 2026-03-31
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-30
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-03-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | Astrana Health, Inc. |
| Ticker | ASTH |
| Exchange | -- |
| Sector | Services |
| Industry | Engineering, Accounting & Management Services |
| Headquarters | ALHAMBRA, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 1.95B |
| Revenue | 3.18B |
| Net Income | 22.49M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 0.7% |
| ROE | 2.9% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...